IL113979A0 - Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of same - Google Patents
Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of sameInfo
- Publication number
- IL113979A0 IL113979A0 IL11397995A IL11397995A IL113979A0 IL 113979 A0 IL113979 A0 IL 113979A0 IL 11397995 A IL11397995 A IL 11397995A IL 11397995 A IL11397995 A IL 11397995A IL 113979 A0 IL113979 A0 IL 113979A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- cardiodilatin fragments
- fragments
- highly purified
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4420381 | 1994-06-02 | ||
DE19513784A DE19513784A1 (de) | 1994-06-02 | 1995-04-10 | Hochreines Urodilatin und Verfahren zu seiner Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
IL113979A0 true IL113979A0 (en) | 1995-10-31 |
Family
ID=25937342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11397995A IL113979A0 (en) | 1994-06-02 | 1995-06-01 | Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of same |
Country Status (8)
Country | Link |
---|---|
US (5) | US5767239A (ja) |
EP (1) | EP0763061B1 (ja) |
JP (2) | JPH10500969A (ja) |
AT (1) | ATE226960T1 (ja) |
AU (1) | AU2671795A (ja) |
ES (1) | ES2188665T3 (ja) |
IL (1) | IL113979A0 (ja) |
WO (1) | WO1995033769A1 (ja) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767239A (en) * | 1994-06-02 | 1998-06-16 | Boehringer Mannheim Gmbh | Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same |
KR100691545B1 (ko) * | 1998-09-28 | 2007-03-09 | 산텐 세이야꾸 가부시키가이샤 | 나트륨 이뇨 펩티드를 유효 성분으로하는 누액 분비 촉진또는 각결막 장해 치료용 점안제 |
UA71608C2 (en) | 1999-03-11 | 2004-12-15 | Merck Patent Gmbh | A method for producing the cyclic pentapeptide |
ES2687786T3 (es) | 2004-04-21 | 2018-10-29 | Alexion Pharmaceuticals, Inc. | Conjugados para administración ósea y procedimiento de uso de estos para dirigir proteínas al hueso |
JP2007513192A (ja) * | 2004-10-04 | 2007-05-24 | ノベタイド,リミティド | ペプチド用の対イオン交換法 |
US7732406B2 (en) | 2005-04-07 | 2010-06-08 | Cardiopep Pharma Gmbh | Use of natriuretic peptide for treating heart failure |
ES2632953T3 (es) * | 2007-07-20 | 2017-09-18 | Mayo Foundation For Medical Education And Research | Polipéptidos natriuréticos |
EP2234603A1 (en) * | 2007-12-19 | 2010-10-06 | EKR Therapeutics, Inc. | Room temperature stable, lyophilized natriuretic peptide formulations |
EP2658979B1 (en) | 2010-12-27 | 2018-02-14 | Alexion Pharmaceuticals, Inc. | Compositions comprising natriuretic peptides and methods of use thereof |
WO2013103896A1 (en) | 2012-01-06 | 2013-07-11 | Mayo Foundation For Medical Education And Research | Treating cardiovascular or renal diseases |
JP6108858B2 (ja) | 2012-02-17 | 2017-04-05 | 株式会社半導体エネルギー研究所 | p型半導体材料および半導体装置 |
US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
WO2014115033A2 (en) | 2013-01-25 | 2014-07-31 | Cardiorentis Ltd. | Methods of treating cardiovascular indications |
CN103145827A (zh) * | 2013-03-04 | 2013-06-12 | 吉尔生化(上海)有限公司 | 一种乌拉力肽的固相合成方法 |
US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
US10449236B2 (en) | 2014-12-05 | 2019-10-22 | Alexion Pharmaceuticals, Inc. | Treating seizure with recombinant alkaline phosphatase |
US10603361B2 (en) | 2015-01-28 | 2020-03-31 | Alexion Pharmaceuticals, Inc. | Methods of treating a subject with an alkaline phosphatase deficiency |
WO2016131943A1 (en) | 2015-02-20 | 2016-08-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of obesity and complications arising therefrom including type 2 diabetes |
RU2745528C2 (ru) | 2015-08-17 | 2021-03-26 | Алексион Фармасьютикалз, Инк. | Производство щелочных фосфатаз |
WO2017058822A1 (en) | 2015-09-28 | 2017-04-06 | Alexion Pharmaceuticals, Inc. | Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia |
EP3368062A4 (en) | 2015-10-30 | 2019-07-03 | Alexion Pharmaceuticals, Inc. | METHODS OF TREATING CRANIOSYNOSTOSIS IN A PATIENT |
CN106928342B (zh) * | 2015-12-31 | 2020-10-16 | 深圳翰宇药业股份有限公司 | 一种乌拉立肽的制备方法 |
WO2017155569A1 (en) | 2016-03-08 | 2017-09-14 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in children |
KR20220162816A (ko) | 2016-04-01 | 2022-12-08 | 알렉시온 파마슈티칼스, 인코포레이티드 | 알칼리성 포스파타아제로 근육 약화의 치료 |
EP3436020A4 (en) | 2016-04-01 | 2019-12-25 | Alexion Pharmaceuticals, Inc. | METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS |
WO2017214130A1 (en) | 2016-06-06 | 2017-12-14 | Alexion Pharmaceuticals, Inc. | Metal impact on manufacturing of alkaline phosphatases |
JP7018933B2 (ja) | 2016-08-18 | 2022-02-14 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 気管気管支軟化症の治療方法 |
MX2019011508A (es) | 2017-03-31 | 2019-11-01 | Alexion Pharma Inc | Metodos para tratar la hipofosfatasia (hpp) en adultos y adolescentes. |
US11913039B2 (en) | 2018-03-30 | 2024-02-27 | Alexion Pharmaceuticals, Inc. | Method for producing recombinant alkaline phosphatase |
EP3805246A4 (en) * | 2018-05-30 | 2022-03-23 | Hybio Pharmaceutical Co., Ltd. | METHODS OF PURIFICATION OF LONG-CHAIN POLYPEPTIDES |
CN110845599B (zh) * | 2018-08-21 | 2022-10-14 | 鲁南制药集团股份有限公司 | 一种多肽的制备纯化方法 |
WO2022029499A1 (en) | 2020-08-06 | 2022-02-10 | Ads Aiphia Development Services Ag | Methods of treating refractory ascites |
WO2022029497A1 (en) | 2020-08-06 | 2022-02-10 | Ads Aiphia Development Services Ag | Ularitide for use in methods of treating refractory ascites |
EP4333846A1 (en) | 2021-05-06 | 2024-03-13 | Rigshospitalet | Diagnosing and treating critically ill subjects |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU572173B2 (en) * | 1983-08-29 | 1988-05-05 | Institut De Recherches Cliniques De Montreal | Natriuretic factors |
DE3346953A1 (de) * | 1983-12-24 | 1985-08-14 | Organogen Medizinisch-Molekularbiologische Forschungsgesellschaft mbH, 6900 Heidelberg | Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung |
WO1985004870A1 (en) * | 1984-04-19 | 1985-11-07 | Biotechnology Research Partners, Ltd. | Novel atrial natriuretic/vasodilator polypeptides |
JPH0672157B2 (ja) * | 1984-08-29 | 1994-09-14 | 味の素株式会社 | 新規ペプチド |
US5057603A (en) * | 1986-01-31 | 1991-10-15 | Merck & Co., Inc. | Peptides having ANF activity |
JP2819467B2 (ja) * | 1987-03-02 | 1998-10-30 | ファーマ・ビッセンドルフ・ペプタイド・ゲーエムベーハー | 新規なカルジオジラチン断片およびその製造方法 |
US5449751A (en) * | 1987-03-02 | 1995-09-12 | Pharma Bissendorf Peptide Gmbh | Cardiodilatin fragment, process for preparing same and use thereof |
US5204327A (en) * | 1988-11-18 | 1993-04-20 | Ashi Kasei Kogyo Kabushiki Kaisha | Treatment of cerebral edema with anp pharmaceutical compositions |
US5767239A (en) * | 1994-06-02 | 1998-06-16 | Boehringer Mannheim Gmbh | Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same |
-
1995
- 1995-05-30 US US08/737,927 patent/US5767239A/en not_active Expired - Lifetime
- 1995-05-30 ES ES95921780T patent/ES2188665T3/es not_active Expired - Lifetime
- 1995-05-30 AT AT95921780T patent/ATE226960T1/de not_active IP Right Cessation
- 1995-05-30 JP JP8500318A patent/JPH10500969A/ja not_active Withdrawn
- 1995-05-30 AU AU26717/95A patent/AU2671795A/en not_active Abandoned
- 1995-05-30 WO PCT/EP1995/002050 patent/WO1995033769A1/de active IP Right Grant
- 1995-05-30 EP EP95921780A patent/EP0763061B1/de not_active Expired - Lifetime
- 1995-06-01 IL IL11397995A patent/IL113979A0/xx unknown
-
1998
- 1998-02-23 US US09/027,777 patent/US20030171536A1/en not_active Abandoned
-
2005
- 2005-03-21 US US11/084,190 patent/US20060122371A1/en not_active Abandoned
- 2005-07-11 JP JP2005202136A patent/JP4130671B2/ja not_active Expired - Lifetime
-
2007
- 2007-07-27 US US11/881,669 patent/US20090240031A1/en not_active Abandoned
-
2010
- 2010-02-09 US US12/702,894 patent/US20100317600A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US5767239A (en) | 1998-06-16 |
EP0763061A1 (de) | 1997-03-19 |
ES2188665T3 (es) | 2003-07-01 |
ATE226960T1 (de) | 2002-11-15 |
US20090240031A1 (en) | 2009-09-24 |
JP2005298526A (ja) | 2005-10-27 |
US20030171536A1 (en) | 2003-09-11 |
AU2671795A (en) | 1996-01-04 |
EP0763061B1 (de) | 2002-10-30 |
US20060122371A1 (en) | 2006-06-08 |
JPH10500969A (ja) | 1998-01-27 |
JP4130671B2 (ja) | 2008-08-06 |
WO1995033769A1 (de) | 1995-12-14 |
US20100317600A1 (en) | 2010-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL113979A0 (en) | Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of same | |
CA2032153A1 (fr) | Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant | |
HUP9903947A2 (hu) | Eljárás neuorotrofinok tisztítására | |
BG101384A (en) | New pesticide proteins and strains | |
CA2176494A1 (en) | Purification of Hemoglobin | |
HUT58764A (en) | Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates | |
AU1155495A (en) | Process for the preparation of non-cariogenic sugars | |
CA2170515A1 (en) | Nucleotide sequences for novel protein tyrosine phosphatases | |
NZ212155A (en) | Purification of protein/peptide material by electroseparation | |
AU5155996A (en) | Control of pod dehiscence | |
MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
ES8608537A1 (es) | Procedimiento de preparacion de 17-(isociano-sulfonilmetileno)-esteroides, 17-(formamido-sulfonilmetileno)-esteroides | |
CA2088068A1 (en) | Protein structure of the plant toxin gelonin | |
ES8704511A1 (es) | Procedimiento para sintetizar peptidos a partir de aminoaci-dos | |
HK1009151A1 (en) | Mpl ligand analogs mpl. | |
WO1988003927A3 (en) | Renin inhibitors | |
MX9806041A (es) | Proteina purificada sr-p70. | |
TW368505B (en) | A process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same | |
AUPM772494A0 (en) | Improvements in production of proteins in host cells | |
UA37217C2 (uk) | Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, фармацевтична композиція та проміжні сполуки | |
MX9700941A (es) | Materiales y metodos para la produccion de icam-4. | |
MY105082A (en) | Separation process | |
AU1662495A (en) | Skin package | |
MX9505097A (es) | 1,4-dihidropiridinas con estructura puente en la posicion 1,2, procedimiento para su obtencion y medicamentos que las contienen. | |
EP0816328A3 (en) | Process for the manufacture of acetonylbenzamides |